Jump to content
The World News Media

Ocaliva Approved for Rare Liver Disease - U.S. News & World Report


Health and Medicine

Recommended Posts

  • Administrator
images?q=tbn:ANd9GcSseq6kAmB2LmkDx434ALX
Bidness ETC

Ocaliva Approved for Rare Liver Disease
U.S. News & World Report
TUESDAY, May 31, 2016 (HealthDay News) -- Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat a rare chronic liver disease called primary biliary cholangitis (PBC). The disease causes the liver's small bile ...
Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a yearMarketWatch
FDA approves Ocaliva for rare, chronic liver diseaseFDA.gov
New Primary Biliary Cholangitis Treatment ApprovedPharmacy Times
Bidness ETC -Benzinga -CNA Finance (press release) -PharmaLive (press release) (subscription)
all 19 news articles »

Google

Link to comment
Share on other sites


  • Views 394
  • Replies 0
  • Created
  • Last Reply

Top Posters In This Topic

Popular Days

Top Posters In This Topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.